Joseph Wagner
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2024
Aktive Positionen von Joseph Wagner
| Unternehmen | Position | Beginn | Ende |
|---|
Karriereverlauf von Joseph Wagner
Ehemalige bekannte Positionen von Joseph Wagner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Direktor/Vorstandsmitglied | 01.06.2015 | 24.03.2016 |
| Vorstandsvorsitzender | 01.06.2015 | 24.03.2016 | |
| Präsident | 01.06.2015 | 24.03.2016 | |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | - | 13.10.2009 |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Präsident | - | - |
| ONCOCYTE CORPORATION | Vorstandsvorsitzender | - | - |
Ausbildung von Joseph Wagner
| Duke University School of Medicine | Doctorate Degree |
| Rochester Christian University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Kanada | 2 |
Operativ
| Chief Executive Officer | 2 |
| President | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |
- Börse
- Insiders
- Joseph Wagner
- Erfahrung
